Supplementary Figure 2 from Temporal Molecular and Biological Assessment of an Erlotinib-Resistant Lung Adenocarcinoma Model Reveals Markers of Tumor Progression and Treatment Response

crossref（2023）

引用 0|浏览3

暂无评分

摘要

PDF file - 242K, EGFR-overexpressing tumors respond after 1 week of treatment by H&E staining and IHC for total EGFR, phospho-EGFR, and Ki-67

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要